The authors demonstrated that miR-30c regulates breast cancer chemoresistance and EMT by direct targeting of the cytoskeleton gene TWF1 and thus by indirect targeting of the cytokine IL-11 [112]. The gene discussed is IL11; the disease is breast carcinoma.